| 查看: 2668 | 回复: 23 | |||
[交流]
帮我分析分析是否中稿呢
|
|||
|
前段时间在IOP上投了篇文章,编辑回复如下: Thank you for your submission which will be considered for publication in *************. The reference number for your article is ********. Please quote this number in all future correspondence regarding this article. 还让填一份assignment of copyright ASSIGNMENT OF COPYRIGHT and DECLARATION OF RESPONSIBILITY 1. IOP Publishing Ltd ("the Publisher" agrees to publishManuscript title: ********************* ("The Article" written by Names of all Authors: ****************************("the Named Authors" ![]() in the following journal: **********************("the Journal" ![]() 2. Transfer of Copyright Agreement 2.1 On acceptance for publication the undersigned author(s) (“Author”) of the Article assigns exclusively to IOP worldwide copyright in the Article for the full term and for all media and formats in all material published as part of the Article, which expression includes but is not limited to the text, abstract, tables, figures and graphs, but excludes any supplementary material. 2.2 If any of the Named Authors are Government employees, on acceptance for publication the Author shall grant IOP a royalty free exclusive licence for the full term of copyright for all media and formats to do in relation to the Article all acts restricted by copyright worldwide. 2.3 On acceptance for publication the Author shall grant IOP a royalty free non-exclusive licence for the full term of copyright for all media and formats to do in relation to any supplementary material deemed to be part of the Article all acts restricted by copyright worldwide. 3. Author Rights 3.1 IOP grants the Named Authors the rights specified in 3.2 and 3.3. All such rights must be exercised for non-commercial purposes, if possible should display citation information and IOP’s copyright notice, and for electronic use best efforts must be made to include a link to the on-line abstract in the Journal. Exercise of the rights in 3.3 additionally must not use the final published IOP format but the Named Author’s own format (which may include amendments made following peer review). 3.2 The rights are: 3.2.1 To make copies of the Article (all or part) for teaching purposes; 3.2.2 To include the Article (all or part) in a research thesis or dissertation; 3.2.3 To make oral presentation of the Article (all or part) and to include a summary and/or highlights of it in papers distributed at such presentations or in conference proceedings; and 3.2.4 All proprietary rights other than copyright. 3.3 The additional rights are to: 3.3.1 Use the Article (all or part) without modification in personal compilations or publications of a Named Author’s own works (provided not created by third party publisher); 3.3.2 Include the Article (all or part) on a Named Author’s own personal web site; 3.3.3 Include the Article (all or part) on web sites of the Institution (including its repository) where a Named Author worked when research for the Article was carried out; and 3.3.4 Include the Article (all or part) on third party web sites including e-print servers, but not on other publisher’s web sites. Signature In signing this Agreement the Author represents and warrants that the Article is the original work of the Named Authors, it has not been published previously in any form (other than as permitted under clause 3.2.2 which fact has been notified to IOP in writing), all Named Authors have participated sufficiently in the conception and writing of the Article, have received the final version of the Article, agree to its submission and take responsibility for it, and submission has been approved as necessary by the authorities at the establishment where the research was carried out. The Author warrants that he/she signs this Agreement as authorised agent for all Named Authors and has the full power to enter into this Agreement and to make the grants it contains, that the Article has not been and will not be submitted to another publisher prior to withdrawal or rejection, it does not infringe any third party rights, it contains nothing libellous or unlawful, all factual statements are to the best of the Author’s knowledge true or based on valid research conducted according to accepted norms, and all required permissions have been obtained in writing. All Named Authors assert their moral rights. Author’s signature………………………………………....………….Date…………………… Signature on behalf of Institution………………………………………Date……………………. |
» 猜你喜欢
面上再次挂了,太难了,躺也躺不了,倦也卷不过,小学校之殇!
已经有27人回复
8月时间戳变的,举个手。玩一下,释放压力
已经有4人回复
UV压敏胶开发
已经有6人回复
有没有H口的?有收到消息的吗?
已经有3人回复
十年后又回来了,论文投稿求助
已经有3人回复
纯娱乐,不喜欢勿喷
已经有10人回复
面上提前没消息,有中的吗
已经有18人回复
娱乐
已经有4人回复
系统今天又提示维护了,估计离放榜不远了
已经有16人回复
一个有机合成实验室都需要哪些设备?
已经有10人回复
» 本主题相关价值贴推荐,对您同样有帮助:
请大家帮我分析这个产物能不能过柱纯化呢?
已经有27人回复
麻烦大家帮我分析分析
已经有4人回复
各位大牛,帮我分析下出国公派读博,是不是离我越来越远了?
已经有27人回复
大家帮我分析下导师的答复,是不是没有什么希望,谢谢大家了!!!
已经有5人回复
这个导师是什么意思呢,大家帮我分析一下吧。
已经有46人回复
哪位高手帮我分析这张幅循环伏安曲线呢
已经有12人回复
北京和深圳,哪个好呢?请大家帮我分析下
已经有28人回复
大家帮我分析分析
已经有4人回复
【求助】大家来帮我分析下是不是要这么久
已经有14人回复
大家帮我分析一下有没有这种可能呢?谢谢
已经有13人回复
» 抢金币啦!回帖就可以得到:
国自然发榜在即:此刻的你,是什么心情?
+2/940
1,2-双(三甲基硅氧基)苯(CAS:5075-52-5)
+1/98
2-氯-1,3,2-二氧磷杂环戊烷(CAS:822-39-9)
+1/98
3-羟基丙腈(CAS:109-78-4)
+1/98
三(三甲基硅基)甘油醚(CAS:6787-10-6 )
+1/97
四(三甲基硅基)赤藓醇醚(CAS:18547-29-0 )
+1/97
丁烯二醇(CAS: 497-06-3)
+1/97
药化高级研究员
+1/77
国家纳米科学中心段鹏飞课题组招收2027年入学博士研究生
+1/77
化工学院邱惠斌教授联合同仁医院招聘博士后
+1/72
2026年University of South Carolina继续招收博士生
+1/61
小木虫是我和国基唯一的人脉,现在都感觉快断了
+1/58
天津工业大学招26师资博后/27博士/科研助理
+1/19
北京理工大学-集成电路与电子学院杰青团队-招博士后
+1/17
北京理工大学-集成电路与电子学院杰青团队-招博士后
+1/17
北理工集成电路杰青团队 | 诚招科助理
+1/17
北理工集成电路杰青团队 | 诚招科助理
+1/16
苏州大学李刚教授课题组博士后招聘公告
+1/12
北京师范大学(珠海校区)赵亚然副教授招收2027年电催化硕士/博士研究生
+1/3
【香港城市大学】范战西教授课题组现招收博士生(全奖, 2027年秋季入学)
+1/3
2楼2011-03-31 15:48:33
3楼2011-03-31 16:13:08
4楼2011-03-31 16:19:31
5楼2011-03-31 16:20:59
6楼2011-03-31 16:23:04
7楼2011-03-31 16:24:25
8楼2011-03-31 16:25:06
10楼2011-03-31 17:11:57
11楼2011-03-31 20:11:42
12楼2011-04-01 09:09:11
13楼2011-04-01 09:11:12
14楼2011-04-01 09:12:57
15楼2011-04-01 09:14:24
16楼2011-04-01 09:15:28
17楼2011-04-01 09:16:10
18楼2011-04-01 09:16:47
19楼2011-04-01 09:17:31
20楼2011-04-01 09:18:25
21楼2011-04-01 09:50:16
22楼2011-04-05 12:42:01
23楼2011-04-05 21:33:45
24楼2012-11-04 11:01:26
简单回复
2011-03-31 16:54
回复










agrees to publish
回复此楼

